Grand Rounds 2010-11

Grand Rounds 2010-11

Endocrine Grand Rounds
2010-2011

Date Speaker Topic
9/14/2010 Ken Saag, MD, MSc (University of Alabama at Birmingham) Use of glucocorticoids in treatment: risks, benefits and choice of agents to prevent GIO
9/21/2010 E. Dale Abel, MD (University of Utah) Novel insights into the cardiovascular consequences of insulin resistance
10/5/2010 Mark DeBoer, MD (Pediatric Endocrinology) Endocrine sequelae of childhood cancer treatment
10/12/2010 Eugene Barrett, MD, PhD Insulin resistance: how it is measured and what are the limitations
10/26/2010 Susanna Keller, MD Rab GAPs and regulation of glucose homeostasis
11/2/2010 Michael Thorner, MBBS, DSc, FRCP, MACP Is insulin resistance friend or foe?
11/9/2010 Sue Brown, MD Denosumab: updates in osteoporosis treatment
11/16/2010 Ayotunde Dokun, MD, PhD Nature and Nurture in the pathogenesis of peripheral arterial disease
11/30/2010 Robin Felder, PhD (Clinical Chemistry and Toxicology) To salt or not to salt: the molecular basis of salt sensitivity
12/14/2010 Michael Sellix, PhD (Biology) Gaining ground while gaining weight: understanding the role of the circadian clock in metabolic disease
12/21/2010 Shetal Padia, MD Obesity-associated hypertension
1/11/2011 Helmy Siragy, MD Is there an ideal treatment for hyponatremia?
1/25/2011 Erica Ungewitter, PhD (NIH, NIEHS) Δ-40p53 controls IGF signaling and stem cell potency
2/1/2011 Mary Lee Vance, MD Prolactinoma: diagnosis and treatment
2/22/2011 Adrian Halme, PhD (Cell Biology)
3/1/2011 Joyce Green-Pastors, RD, MS, CDE, & Terry Saunders, PhD
The use of standardized patient cases to teach diabetes clinical care skills to general medicine residents on Endocrine rotation
3/8/2011 William F. Young, Jr, MD, MSc, ELS (Mayo Clinic) (Crispell Lecture)
Pheochromocytoma: Tricks and Traps
3/15/2011 Farah Morgan, MD / Jennifer Kirby, MD, PhD Metabolic consequences of HIV and its treatment (Morgan) / Osteoporosis in men: risk factors, screening, and treatment (Kirby)
3/22/2011 Eugene Barrett, MD, PhD Cardiovascular disease and diabetes - when and how to intervene?
4/5/2011 Matthew Sauder, MD From Greenland to New Zealand: exploring alternative therapies in endocrinology
4/12/2011 Ken Burman, MD (Washington Hospital Center) Differentiated thyroid cancer: recent advances
4/19/2011 Kenneth Brayman, MD, PhD (Surgery)
Update on beta cell replacement therapy
4/26/2011 Darlene Berryman, PhD, RD (Ohio University)
Growth hormone and adipose tissue: it's all in the depot
5/3/2011 Christopher McCartney, MD Cross-sex hormone administration to persons with gender identity disorder: philosophical and practical dilemmas
5/10/2011 Jennifer Beller, MD / William Smith, MD
Premature ovarian failure: evaluation and treatment considerations (Beller) / Male infertility: and endocrinological perspective (Smith)
5/17/2011 Gregory Hong, MD, PhD / Jessicah Collins, MD Sepsis and adrenal insufficiency: is it worth stressing over? (Hong) / Polycystic ovary syndrome and disordered sleep (Collins)
5/24/2011 Charles Upchurch, MD / Cristina Gherghe, MD, PhD Microalbuminuria and cardiovascular outcomes (Upchurch) / Please don't stress! (Gherghe)
5/31/2011 Rodney Snow, MD